On Friday, high-profile investors Michael Burry and Warren Buffett took positions in UnitedHealth Group Inc. (NYSE:UNH).

Buffett's $1.57B bet on UNH sparks a 12% surge, lifting peers despite sector headwinds and recent struggles at the insurer.

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

Stocks were mostly higher Monday as President Donald Trump was scheduled to meet with Ukraine President Volodymyr Zelensky ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a [form of liver disease]( ...

Fresh off a 12% surge on the news that Warren Buffett's Berkshire Hathaway, as well as other leading investors, purchased the ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

This investment signifies Buffett's re-entry into UNH after liquidating his entire position back in 2010, indicating that he perceives significant value at ...

It has been a rough year for healthcare stocks on the S&P 500, but Warren Buffett’s move into UnitedHealth Group Inc. could ...

UnitedHealth Group Incorporated (NYSE:UNH)’s Q2 2025 revenues increased $12.8 billion YoY to $111.6 billion. This was aided ...

President Donald Trump on Aug. 13 revoked Executive Order 14036, a 2021 directive issued under the Biden administration aimed at promoting competition across the U.S. economy, including healthcare.